Ryan Halsted Analyst PerformanceManaging Director at Royal Bank Of CanadaRyan Halsted is a stock analyst at Royal Bank Of Canada focused in the healthcare sector, covering 12 publicly traded companies. Over the past year, Ryan Halsted has issued 24 stock ratings, including buy and hold recommendations. While full access to Ryan Halsted's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ryan Halsted's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings25 Last 10 YearsBuy Recommendations68.00% 17 Buy RatingsCompanies Covered12 Unique Companies Ratings Distribution25RatingsDistribution of strong buy, buy, hold, and sell ratings by Ryan Halsted.RatingPercentageCount Strong Buy0.0%0 ratings Buy68.0%17 ratings Hold32.0%8 ratings Sell0.0%0 ratingsOut of 25 total stock ratings issued by Ryan Halsted at Royal Bank Of Canada, the majority (68.0%) have been Buy recommendations, followed by 32.0% Hold.Best & Worst CallsThis analyst does not have any ratings with enough history to determine best and worst calls.Exchange CoverageExchangePercentageCountNASDAQ66.7% of companies on NASDAQ8 companiesNYSE33.3% of companies on NYSE4 companiesRyan Halsted, an analyst at Royal Bank Of Canada, currently covers 12 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare11 companies91.7%Industrials1 company8.3%Ryan Halsted of Royal Bank Of Canada specializes in stock coverage within the Healthcare sector, with additional focus on Industrials companies.Coverage IndustriesIndustryPercentageLIFE SCIENCES TOOLS & SERVICES4 companies33.3%HEALTHCARE PROVIDERS & SERVICES3 companies25.0%HEALTHCARE TECHNOLOGY3 companies25.0%HEALTHCARE EQUIPMENT & SUPPLIES1 company8.3%COMMERCIAL SERVICES & SUPPLIES1 company8.3% Ryan Halsted's Ratings History at Royal Bank Of Canada Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsIQVIQVIA7/29/2026Boost Price Target$246.01$247.00Outperform$0.0000.00% ROIMEDPMedpace7/24/2026Boost Price Target$601.74$692.00Outperform$0.0000.00% ROIICLRIcon6/25/2026Upgrade$158.17$185.00Outperform$0.0000.00% ROIHQYHealthEquity6/3/2026Boost Price Target$88.34$108.00Outperform$0.0000.00% ROIICLRIcon5/29/2026Boost Price Target$136.80$126.00Sector Perform$0.0000.00% ROIHQYHealthEquity5/29/2026Boost Price Target$87.36$108.00Outperform$0.0000.00% ROIICLRIcon5/18/2026Initiated Coverage$115.73$123.00Sector Perform$0.0000.00% ROIMEDPMedpace4/24/2026Lower Price Target$393.42$484.00Outperform$0.0000.00% ROIHCSGHealthcare Services Group4/23/2026Boost Price Target$22.08$24.00Sector Perform$0.0000.00% ROIDOCSDoximity3/9/2026Reiterated Rating$24.72$44.00Outperform$0.0000.00% ROIMEDPMedpace3/3/2026Initiated Coverage$457.47$522.00Outperform$0.0000.00% ROIIQVIQVIA3/3/2026Initiated Coverage$174.48$221.00Outperform$0.0000.00% ROIHCSGHealthcare Services Group3/3/2026Initiated Coverage$22.22$22.00Sector Perform$0.0000.00% ROIMEDPMedpace3/2/2026Upgrade$465.38Moderate Buy$0.0000.00% ROIMDLNMedline2/26/2026Boost Price Target$50.56$53.00Outperform$0.0000.00% ROIEVHEvolent Health2/25/2026Lower Price Target$3.12$3.00Sector Perform$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$40.52$47.00Outperform$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$42.72$47.00Outperform$0.0000.00% ROITBRGTruBridge1/9/2026Initiated Coverage$22.70$23.00Sector Perform$0.0000.00% ROIPRVAPrivia Health Group1/9/2026Initiated Coverage$23.15$31.00Outperform$0.0000.00% ROIPRVAPrivia Health Group1/8/2026Upgrade$23.04Moderate Buy$0.0000.00% ROITBRGTruBridge1/8/2026Upgrade$21.51Hold$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsMizuho Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
